256 related articles for article (PubMed ID: 33511201)
1. Comparison of Effects of a Thrombin-Based Hemostatic Agent and Topical Tranexamic Acid on Blood Loss in Patients with Preexisting Thromboembolic Risk Undergoing a Minimally Invasive Total Knee Arthroplasty. A Prospective Randomized Controlled Trial.
Yen SH; Lin PC; Wu CT; Wang JW
Biomed Res Int; 2021; 2021():2549521. PubMed ID: 33511201
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Floseal® and Tranexamic Acid for Bleeding Control after Total Knee Arthroplasty: a Prospective Randomized Study.
Helito CP; Bonadio MB; Sobrado MF; Giglio PN; Pécora JR; Camanho GL; Demange MK
Clinics (Sao Paulo); 2019; 74():e1186. PubMed ID: 31778430
[TBL] [Abstract][Full Text] [Related]
3. High-dose (3 g) topical tranexamic acid has higher potency in reducing blood loss after total knee arthroplasty compared with low dose (500 mg): a double-blind randomized controlled trial.
Tammachote N; Raphiphan R; Kanitnate S
Eur J Orthop Surg Traumatol; 2019 Dec; 29(8):1729-1735. PubMed ID: 31359178
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial.
Kim HJ; Fraser MR; Kahn B; Lyman S; Figgie MP
J Bone Joint Surg Am; 2012 Jul; 94(13):1160-5. PubMed ID: 22623075
[TBL] [Abstract][Full Text] [Related]
5. Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial.
Pinsornsak P; Rojanavijitkul S; Chumchuen S
BMC Musculoskelet Disord; 2016 Jul; 17():313. PubMed ID: 27455842
[TBL] [Abstract][Full Text] [Related]
6. Combined intravenous and intra-articular tranexamic acid administration in total knee arthroplasty for preventing blood loss and hyperfibrinolysis: A randomized controlled trial.
Zhang YM; Yang B; Sun XD; Zhang Z
Medicine (Baltimore); 2019 Feb; 98(7):e14458. PubMed ID: 30762760
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial.
Wang JW; Chen B; Lin PC; Yen SH; Huang CC; Kuo FC
J Arthroplasty; 2017 Mar; 32(3):801-806. PubMed ID: 27663190
[TBL] [Abstract][Full Text] [Related]
8. A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty.
Mao Z; Yue B; Wang Y; Yan M; Dai K
BMC Musculoskelet Disord; 2016 Oct; 17(1):438. PubMed ID: 27760536
[TBL] [Abstract][Full Text] [Related]
9. Most Effective Regimen of Tranexamic Acid for Reducing Bleeding and Transfusions in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials.
Dai WL; Zhou AG; Zhang H; Zhang J
J Knee Surg; 2018 Aug; 31(7):654-663. PubMed ID: 28895645
[TBL] [Abstract][Full Text] [Related]
10. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis.
Shin YS; Yoon JR; Lee HN; Park SH; Lee DH
Knee Surg Sports Traumatol Arthrosc; 2017 Nov; 25(11):3585-3595. PubMed ID: 27417102
[TBL] [Abstract][Full Text] [Related]
11. Comparison of oral versus intra-articular tranexamic acid in enhanced-recovery primary total knee arthroplasty without tourniquet application: a randomized controlled trial.
Wang D; Zhu H; Meng WK; Wang HY; Luo ZY; Pei FX; Li Q; Zhou ZK
BMC Musculoskelet Disord; 2018 Mar; 19(1):85. PubMed ID: 29544472
[TBL] [Abstract][Full Text] [Related]
12. Topical Tranexamic Acid Reduces Blood Loss in Minimally Invasive Total Knee Arthroplasty Receiving Rivaroxaban.
Yen SH; Lin PC; Chen B; Huang CC; Wang JW
Biomed Res Int; 2017; 2017():9105645. PubMed ID: 29410968
[TBL] [Abstract][Full Text] [Related]
13. [Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty].
Lošťák J; Gallo J; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2016; 83(4):254-262. PubMed ID: 28026726
[TBL] [Abstract][Full Text] [Related]
14. Prospective, randomized trial to evaluate efficacy of a thrombin-based hemostatic agent in total knee arthroplasty.
Suarez JC; Slotkin EM; Alvarez AM; Szubski CR; Barsoum WK; Patel PD
J Arthroplasty; 2014 Oct; 29(10):1950-5. PubMed ID: 25015756
[TBL] [Abstract][Full Text] [Related]
15. Effect of knee flexion position and combined application of tranexamic acid on blood loss following primary total knee arthroplasty: a prospective randomized controlled trial.
Zeng Y; Si H; Li C; Wu Y; Shen B
Int Orthop; 2018 Mar; 42(3):529-535. PubMed ID: 29396806
[TBL] [Abstract][Full Text] [Related]
16. Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study.
Morales Santias M; Mas Martinez J; Sanz-Reig J; Martínez Gimenez E; Verdu Román C; Bustamante Suarez de Puga D
Eur J Orthop Surg Traumatol; 2020 Aug; 30(6):1003-1008. PubMed ID: 32185573
[TBL] [Abstract][Full Text] [Related]
17. Combined Intra-Articular and Intravenous Tranexamic Acid Reduces Blood Loss in Total Knee Arthroplasty: A Randomized, Double-Blind, Placebo-Controlled Trial.
Nielsen CS; Jans Ø; Ørsnes T; Foss NB; Troelsen A; Husted H
J Bone Joint Surg Am; 2016 May; 98(10):835-41. PubMed ID: 27194493
[TBL] [Abstract][Full Text] [Related]
18. Combined Administration of Systemic and Topical Tranexamic Acid for Total Knee Arthroplasty: Can It Be a Better Regimen and Yet Safe? A Randomized Controlled Trial.
Jain NP; Nisthane PP; Shah NA
J Arthroplasty; 2016 Feb; 31(2):542-7. PubMed ID: 26507526
[TBL] [Abstract][Full Text] [Related]
19. Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial.
Wang HY; Wang L; Luo ZY; Wang D; Tang X; Zhou ZK; Pei FX
BMC Musculoskelet Disord; 2019 Oct; 20(1):478. PubMed ID: 31653221
[TBL] [Abstract][Full Text] [Related]
20. Multi-route applications of tranexamic acid to reduce blood loss after total knee arthroplasty: a randomized controlled trial.
Zhang S; Wang C; Shi L; Xue Q
Medicine (Baltimore); 2019 Jul; 98(30):e16570. PubMed ID: 31348286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
